Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
As an electrophilic nitroalkene fatty acid, nitro-oleic acid (OA-NO2) exerts multiple biological effects that contribute to anti-inflammation, anti-oxidative stress and anti-apoptosis. However, little is known about the role of OA-NO2 in peritoneal fibrosis. Thus, in this study, we examined the effects of OA-NO2 on the high glucose-induced epithelial-mesenchymal transition (EMT) in human peritoneal mesothelial cells (HPMCs) and evaluated the morphological and immunohistochemical changes in a rat model of peritoneal dialysis (PD)-related peritoneal fibrosis. In an in vitro study, we found that HG reduced the expression level of E-cadherin and increased snail, N-cadherin and α-SMA expression levels in the HPMCs. The abovementioned changes were attenuated by pre-treatment with OA-NO2. Additionally, OA-NO2 also inhibited the HG-induced activation of the TGF-β1/Smads signalling pathway and the NF-κB signalling pathways. Meanwhile, OA-NO2 could inhibited the HG-induced phosphorylation of Erk and JNK. The results from the in vivo study showed that OA-NO2 notably relieved peritoneal fibrosis by decreasing the thickness of the peritoneum; it also inhibited the expression of TGF-β1, α-SMA, N-cadherin and vimentin and enhanced the expression of E-cadherin in the peritoneum. Collectively, these results suggest that OA-NO2 inhibits HG-induced EMT in HPMCs and attenuates peritoneal dialysis-related peritoneal fibrosis.